Keefe, Bruyette & Woods cut shares of HIVE Blockchain Technologies (CVE:HIV – Free Report) from a moderate buy rating to a hold rating in a research report sent to investors on Tuesday morning,Zacks.com reports.
Separately, B. Riley upgraded HIVE Blockchain Technologies to a “strong-buy” rating in a report on Friday, November 21st. Two analysts have rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, HIVE Blockchain Technologies presently has an average rating of “Buy”.
Check Out Our Latest Analysis on HIV
HIVE Blockchain Technologies Stock Performance
Featured Stories
- Five stocks we like better than HIVE Blockchain Technologies
- Buy this Gold Stock Before May 2026
- America’s Next Power Move Starts Underground
- Your Signature Is Missing – Act Before It’s Too Late
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Refund From 1933: Trump’s Reset May Create Instant Wealth
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
